Maly Fenelus

759 total citations
11 papers, 58 citations indexed

About

Maly Fenelus is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Maly Fenelus has authored 11 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Maly Fenelus's work include Peptidase Inhibition and Analysis (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Cancer-related Molecular Pathways (2 papers). Maly Fenelus is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Cancer-related Molecular Pathways (2 papers). Maly Fenelus collaborates with scholars based in United States, Australia and Canada. Maly Fenelus's co-authors include Wilbur B. Bowne, Lisa Rosen, Rubina Cocker, Stephen S. Raab, Victor Adler, Karen Chau, Matthew R. Pincus, Melissa Klein, Josef Michl and Allen W. Zhang and has published in prestigious journals such as Blood, Cancer Research and Journal of Thrombosis and Haemostasis.

In The Last Decade

Maly Fenelus

9 papers receiving 58 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maly Fenelus United States 4 26 24 22 8 6 11 58
C Tanabalan United Kingdom 2 36 1.4× 11 0.5× 21 1.0× 13 1.6× 3 0.5× 6 61
William P. Duggan Ireland 5 23 0.9× 19 0.8× 19 0.9× 2 0.3× 4 0.7× 24 64
Vanesa Gutiérrez Calderón Spain 5 16 0.6× 29 1.2× 12 0.5× 3 0.4× 8 1.3× 7 54
Jay Gokhale United Kingdom 5 22 0.8× 11 0.5× 15 0.7× 8 1.0× 12 2.0× 14 84
Amin Ali United Kingdom 3 19 0.7× 10 0.4× 10 0.5× 9 1.1× 2 0.3× 5 66
Amani N. Alansari Qatar 4 23 0.9× 9 0.4× 24 1.1× 7 1.2× 26 63
Fariborz Mansour-Ghanaei Iran 2 18 0.7× 16 0.7× 14 0.6× 13 2.2× 2 64
Gustavo Andreazza Laporte Brazil 5 23 0.9× 20 0.8× 9 0.4× 8 1.3× 17 62
Benjamin Pradere France 3 67 2.6× 10 0.4× 19 0.9× 10 1.3× 3 0.5× 17 78
Raquel Ortigão Portugal 5 47 1.8× 21 0.9× 19 0.9× 13 2.2× 16 97

Countries citing papers authored by Maly Fenelus

Since Specialization
Citations

This map shows the geographic impact of Maly Fenelus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maly Fenelus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maly Fenelus more than expected).

Fields of papers citing papers by Maly Fenelus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maly Fenelus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maly Fenelus. The network helps show where Maly Fenelus may publish in the future.

Co-authorship network of co-authors of Maly Fenelus

This figure shows the co-authorship network connecting the top 25 collaborators of Maly Fenelus. A scholar is included among the top collaborators of Maly Fenelus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maly Fenelus. Maly Fenelus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Derkach, Andriy, et al.. (2025). Venous thromboembolism in patients with cancer and factor XI deficiency. Journal of Thrombosis and Haemostasis. 23(10). 3286–3294.
3.
Morjaria, Sejal, J.W. Frame, Allen W. Zhang, et al.. (2020). Rethinking the need for a platelet transfusion threshold of 50 × 109/L for lumbar puncture in cancer patients. Transfusion. 60(10). 2243–2249. 7 indexed citations
5.
Fenelus, Maly & Ellinor I.B. Peerschke. (2018). HITTING the Diagnosis. American Journal of Clinical Pathology. 150(2). 116–120. 1 indexed citations
6.
Epstein‐Peterson, Zachary D., Gerald A. Soff, Maly Fenelus, & Deborah Korenstein. (2018). Folate Testing and Deficiency in Hospitalized Cancer Patients. Blood. 132(Supplement 1). 5814–5814. 1 indexed citations
7.
Fenelus, Maly, Abhishek Sarkar, Paul Zolkind, et al.. (2014). The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.. PubMed. 44(3). 241–8. 14 indexed citations
8.
Chau, Karen, Lisa Rosen, Maly Fenelus, et al.. (2014). Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution. Cancer Cytopathology. 123(1). 10–18. 23 indexed citations
9.
Fenelus, Maly, Lisa Rosen, Ana Yuil‐Valdes, et al.. (2012). Review of Accuracy of Urinary Cytology with Risk of Malignancy Assessment per Cytology Categories in a Large Tertiary Health Care System. Journal of the American Society of Cytopathology. 1(1). S24–S24. 1 indexed citations
10.
Pincus, Matthew R., et al.. (2011). Anti-cancer Peptides from Ras-P21 and P53 Proteins. Current Pharmaceutical Design. 17(25). 2677–2698. 3 indexed citations
11.
Fenelus, Maly, Paul Zolkind, Victor Adler, et al.. (2011). Abstract 5488: Novel death pathway in a p53 null human leukemia cell line treated with PNC-27. Cancer Research. 71(8_Supplement). 5488–5488. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026